News
NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has ...
Coinbase CEO Brian Armstrong believes this situation can be reversed, and says a health startup he cofounded is making faster ...
Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a ...
Brian Armstrong’s NewLimit raises a $130M Series B, laying out road map for anti-aging drugs
NewLimit raises $130M Series B led by Kleiner Perkins to advance epigenetic reprogramming research for liver disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results